227 related articles for article (PubMed ID: 28408104)
21. I(f) current inhibitor ivabradine in patients with idiopathic dilated cardiomyopathy: Impact on the exercise tolerance and quality of life.
Abdel-Salam Z; Rayan M; Saleh A; Abdel-Barr MG; Hussain M; Nammas W
Cardiol J; 2015; 22(2):227-32. PubMed ID: 25179314
[TBL] [Abstract][Full Text] [Related]
22. Prescription of cardiovascular drugs in the French ODIN cohort of heart failure patients according to age and type of chronic heart failure.
Juillière Y; Suty-Selton C; Riant E; Darracq JP; Dellinger A; Labarre JP; Druelle J; Mulak G; Danchin N; Jourdain P;
Arch Cardiovasc Dis; 2014 Jan; 107(1):21-32. PubMed ID: 24388162
[TBL] [Abstract][Full Text] [Related]
23. Ivabradine: Heart Failure and Beyond.
Chaudhary R; Garg J; Krishnamoorthy P; Shah N; Lanier G; Martinez MW; Freudenberger R
J Cardiovasc Pharmacol Ther; 2016 Jul; 21(4):335-43. PubMed ID: 26721645
[TBL] [Abstract][Full Text] [Related]
24. BNP-guided vs symptom-guided heart failure therapy: the Trial of Intensified vs Standard Medical Therapy in Elderly Patients With Congestive Heart Failure (TIME-CHF) randomized trial.
Pfisterer M; Buser P; Rickli H; Gutmann M; Erne P; Rickenbacher P; Vuillomenet A; Jeker U; Dubach P; Beer H; Yoon SI; Suter T; Osterhues HH; Schieber MM; Hilti P; Schindler R; Brunner-La Rocca HP;
JAMA; 2009 Jan; 301(4):383-92. PubMed ID: 19176440
[TBL] [Abstract][Full Text] [Related]
25. The effects of ivabradine on left atrial electromechanical function in patients with systolic heart failure.
Ozturk S; Öztürk S; Erdem FH; Erdem A; Ayhan S; Dönmez İ; Yazıcı M
J Interv Card Electrophysiol; 2016 Sep; 46(3):253-8. PubMed ID: 27039084
[TBL] [Abstract][Full Text] [Related]
26. Advances in the management of heart failure: the role of ivabradine.
Müller-Werdan U; Stöckl G; Werdan K
Vasc Health Risk Manag; 2016; 12():453-470. PubMed ID: 27895488
[TBL] [Abstract][Full Text] [Related]
27. Effects of ivabradine therapy on heart failure biomarkers.
Ordu S; Yildiz BS; Alihanoglu YI; Ozsoy A; Tosun M; Evrengul H; Kaftan HA; Ozhan H
Cardiol J; 2015; 22(5):501-9. PubMed ID: 25733317
[TBL] [Abstract][Full Text] [Related]
28. Ivabradine in combination with beta-blocker reduces symptoms and improves quality of life in elderly patients with stable angina pectoris: age-related results from the ADDITIONS study.
Müller-Werdan U; Stöckl G; Ebelt H; Nuding S; Höpfner F; Werdan K;
Exp Gerontol; 2014 Nov; 59():34-41. PubMed ID: 25193811
[TBL] [Abstract][Full Text] [Related]
29. [Alternative therapy with ivabradine in patients with functional class III chronic heart failure].
Kanorskiĭ SG; Tregubov VG; Pokrovskiĭ VM
Kardiologiia; 2011; 51(8):39-44. PubMed ID: 21942957
[TBL] [Abstract][Full Text] [Related]
30. Heart rate as a risk factor in chronic heart failure (SHIFT): the association between heart rate and outcomes in a randomised placebo-controlled trial.
Böhm M; Swedberg K; Komajda M; Borer JS; Ford I; Dubost-Brama A; Lerebours G; Tavazzi L;
Lancet; 2010 Sep; 376(9744):886-94. PubMed ID: 20801495
[TBL] [Abstract][Full Text] [Related]
31. Effects of high-dose furosemide and small-volume hypertonic saline solution infusion in comparison with a high dose of furosemide as bolus in refractory congestive heart failure: long-term effects.
Licata G; Di Pasquale P; Parrinello G; Cardinale A; Scandurra A; Follone G; Argano C; Tuttolomondo A; Paterna S
Am Heart J; 2003 Mar; 145(3):459-66. PubMed ID: 12660669
[TBL] [Abstract][Full Text] [Related]
32. Cost-Effectiveness of Ivabradine for Heart Failure in the United States.
Kansal AR; Cowie MR; Kielhorn A; Krotneva S; Tafazzoli A; Zheng Y; Yurgin N
J Am Heart Assoc; 2016 May; 5(5):. PubMed ID: 27153871
[TBL] [Abstract][Full Text] [Related]
33. Ivabradine for the treatment of chronic heart failure.
Henri C; O'Meara E; De Denus S; Elzir L; Tardif JC
Expert Rev Cardiovasc Ther; 2016; 14(5):553-61. PubMed ID: 26967048
[TBL] [Abstract][Full Text] [Related]
34. Nemaline myopathy and heart failure: role of ivabradine; a case report.
Sarullo FM; Vitale G; Di Franco A; Sarullo S; Salerno Y; Vassallo L; Baviera EP; Marazia S; Mandalà G; Lanza GA
BMC Cardiovasc Disord; 2015 Jan; 15():5. PubMed ID: 25597856
[TBL] [Abstract][Full Text] [Related]
35. Management of elderly patients with congestive heart failure--design of the Trial of Intensified versus standard Medical therapy in Elderly patients with Congestive Heart Failure (TIME-CHF).
Brunner-La Rocca HP; Buser PT; Schindler R; Bernheim A; Rickenbacher P; Pfisterer M;
Am Heart J; 2006 May; 151(5):949-55. PubMed ID: 16644310
[TBL] [Abstract][Full Text] [Related]
36. Ivabradine improves quality of life in subjects with chronic heart failure compared to treatment with β-blockers: results of a multicentric observational APULIA study.
Riccioni G; Masciocco L; Benvenuto A; Saracino P; De Viti D; Massari F; Meliota G; Buta F; Speziale G
Pharmacology; 2013; 92(5-6):276-80. PubMed ID: 24296869
[TBL] [Abstract][Full Text] [Related]
37. Initiating ivabradine during hospitalization in patients with acute heart failure: A real-world experience in China.
Liu YX; Chen W; Lin X; Zhu YL; Lai JZ; Li JY; Guo XX; Yang J; Qian H; Zhu YY; Wu W; Fang LG
Clin Cardiol; 2022 Sep; 45(9):928-935. PubMed ID: 35870176
[TBL] [Abstract][Full Text] [Related]
38. Ivabradine, a novel medication for treatment of heart failure with reduced ejection fraction.
Foster JL; Bobadilla RV
J Am Assoc Nurse Pract; 2016 Nov; 28(11):576-582. PubMed ID: 27215699
[TBL] [Abstract][Full Text] [Related]
39. Ivabradine: Do the Benefits Outweigh the Risks?
Alshammari TM
J Cardiovasc Pharmacol Ther; 2017 May; 22(3):210-218. PubMed ID: 27698078
[TBL] [Abstract][Full Text] [Related]
40. Clinical Experience with Ivabradine in Acute Heart Failure.
Pascual Izco M; Alonso Salinas GL; Sanmartín Fernández M; Del Castillo Carnevalli H; Jiménez Mena M; Camino López A; Zamorano Gómez JL
Cardiology; 2016; 134(3):372-4. PubMed ID: 27100325
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]